US Session Top Movers: FISN, XHLD, TLS Lead Gainers; ZURA, SOC, PLCE Lead Losers
Estrella Immunopharma Inc ESLA
$0.75
▲ +45.13%
(+$0.23)
⬆️ Above Yest. High
📅 Earnings This Week
Open
$0.51
Prev Close
$0.51
Day Range
$0.51 – $0.77
52W Range
$0.24 – $3.01
Market Cap
$22.35M
Beta
0.95
EPS (TTM)
$-0.25
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-19 |
| Shares Out. | 43,500,000 |
| Website | estrellabio.com/ ↗ |
| Phone | 13026365400 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$2.3M |
| Free Cash Flow | -$9.4M |
| Total Assets | $1.8M |
| Total Liabilities | $9.3M |
| Equity | -$7.4M |
About Estrella Immunopharma Inc
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Estrella Immunopharma Inc is a publicly traded company under the ticker symbol ESLA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-08-01)